MedTrace Logo

Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)

NCT04734041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-07-15

No results posted yet for this study

Summary

A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)

Conditions

  • Ehlers-Danlos Syndrome
  • Hypermobile EDS (hEDS)
  • Hypermobility Syndrome
  • EDS

Interventions

BEHAVIORAL

Anti-inflammatory (Mediterranean-style) diet

Prescription of an anti-inflammatory diet, which encourages increasing whole fruits, vegetables, and grains, as well as balancing macronutrients (proteins, carbohydrates, and fat) for every meal.

BEHAVIORAL

Behavioral and psychosocial support

Capture a complete and detailed medical history and background. Discuss familial and social support, provide psychosocial support, assess the patient's current self-management strategies for self-care, and assess the patient's current self-management strategies for mental health. Recommendations will be made in accordance with the needs of the participant.

Sponsors & Collaborators

  • Healthy Living Community

    collaborator UNKNOWN

  • National University of Natural Medicine

    lead OTHER

Principal Investigators

  • Rich Barrett, ND · NUNM Institutional Review Board Chair

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-23
Primary Completion
2021-07-02
Completion
2021-07-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734041 on ClinicalTrials.gov